Anpac Bio Presenting 'Unprecedented' Cerebral Cancer Liquid Biopsy Research Results at ASCO 2019

Thursday, May 30, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

The American Society of Clinical Oncology #ASCO has published/posted Anpac Bio’s Non-Small Cell Lung Cancer early detection screening research study Abstract, “A novel biophysical based marker with multilevel, multiparameter expression for early stage cancer detection.” The Abstract demonstrates Anpac Bio’s “Cancer Differentiation Analysis” liquid biopsy technology identified Stage I NSCLC with significant accuracy-achieving 85% sensitivity and 93% specificity from simple, standard blood tests.

Anpac Bio-Medical Science Company will be at Booth #21103 at the American Society of Clinical Oncology #ASCO Annual Meeting in Chicago, IL, May 31-June 4, 2019. The #AnpacBio team will share information regarding its breakthrough, "Cancer Differentiation Analysis" liquid biopsy technology research, demonstrating CDA identifies 28+ early-stage cancers with a single, standard blood sample. Anpac Bio will also share cerebral cancer research results at a Poster Session on Sunday, June 2, 2019.

International life sciences leader Anpac Bio-Medical Science Company has developed breakthrough, proprietary, "Cancer Differentiation Analysis" liquid biopsy technology that effectively reinvents cancer screening and early detection. Anpac Bio's proprietary CDA medical devices analyze simple, standard, non-invasive "Blood Biopsies" - resulting in measurably greater early cancer detection sensitivity and specificity, with no harmful side effects in patients. The proven results of 120,000 cases to date demonstrate CDA's research validity achieving an average sensitivity and specificity rate range of 75%-90% for 28+ different types of cancer -- often identifying the type and location of threatening, diseased cancer cells before they form into tumors. Fully-commercialized and the only company earning liquid biopsy revenue globally, Anpac Bio has filed 250+ CDA-related Patents; 101+ issued to date worldwide. For more information: AnpacBio.com. (PRNewsFoto/Anpac Bio-Medical Science Co.)



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store